Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections
Increasing evidence suggests that dalbavancin is an effective long-term treatment for ventricular assist device (VAD) infections, with various prolonged dosing regimens currently in use. This retrospective study aimed to assess dalbavancin pharmacokinetics in VAD patients and identify optimal, feasi...
Saved in:
| Main Authors: | Ute Chiriac, Uwe Liebchen, Otto Roman Frey, Heike Lanzinger, Sabrina Klein, Torsten Hoppe-Tichy, Matthias Karck, Anna Meyer, Benedict Morath |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/13/11/1103 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-2: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Acetate Buffer with and Without Divalent Metal Ions
by: Sardar M. Jakaria, et al.
Published: (2024-11-01) -
Off-Label Use of Dalbavancin in <i>Enterococcus</i> spp. Abscess and <i>Streptococcus pneumoniae</i> Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report
by: Miriam Banoub Morkos, et al.
Published: (2024-09-01) -
Using Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients: A Real-Life, Single-Center Observational Study
by: Alessandra Oliva, et al.
Published: (2025-01-01) -
Dalbavancin Use in Bone and Joint Infections
by: Liam P. Alderson, BS, et al.
Published: (2024-12-01) -
Safety and Efficacy of Dalbavancin in Real Life: Retrospective Analysis of a Large Monocentric Case Series of Patients Treated for Skin/Soft Tissue and Other Difficult-to-Treat Infections
by: Giustino Parruti, et al.
Published: (2024-11-01)